These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11966450)

  • 1. Vinorelbine in the treatment of non-small cell lung cancer.
    Gridelli C; De Vivo R
    Curr Med Chem; 2002 Apr; 9(8):879-91. PubMed ID: 11966450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vinorelbine for non-small cell lung cancer].
    Seto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract]   [Full Text] [Related]  

  • 4. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
    Goa KL; Faulds D
    Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term analysis of survival in the European randomized trial comparing vinorelbine/cisplatin to vindesine/cisplatin and vinorelbine alone in advanced non-small cell lung cancer.
    Le Chevalier T; Brisgand D; Soria JC; Douillard JY; Pujol JL; Ruffie P; Aberola V; Cigolari S
    Oncologist; 2001; 6 Suppl 1():8-11. PubMed ID: 11181998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma].
    Bartsch V
    Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC.
    Evans WK
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 4):18-25; discussion 25-6. PubMed ID: 9556779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V; Quoix E; Moro-Sibilot D; Mercier M; Breton JL; Debieuvre D; Richard P; Haller MA; Milleron B; Herman D; Level MC; Lebas FX; Puyraveau M; Depierre A;
    J Natl Cancer Inst; 2005 Apr; 97(7):499-506. PubMed ID: 15812075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancer.
    Vokes EE
    Oncology (Williston Park); 1995 Jun; 9(6):565-74, 577; discussion 577-8, 581-. PubMed ID: 8719102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine (navelbine) in the treatment of non-small-cell lung cancer: recent developments in combination chemotherapy and radiotherapy.
    Gralla R; Harper P; Johnson S; Delgado FM
    Ann Oncol; 1999; 10 Suppl 5():S47-51. PubMed ID: 10582139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update: vinorelbine (navelbine) in non-small cell lung cancer.
    Crawford J
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment.
    Caffo O; Dipasquale M; Murgia V; Veccia A; Galligioni E
    Expert Opin Drug Metab Toxicol; 2013 Aug; 9(8):1037-51. PubMed ID: 23705788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
    Goss GD; Logan DM; Newman TE; Evans WK
    Cancer Prev Control; 1997; 1(1):28-38. PubMed ID: 9765724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of non-small cell lung cancer in the elderly.
    Gridelli C
    Lung Cancer; 2002 Dec; 38 Suppl 3():S67-70. PubMed ID: 12468150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-agent vinorelbine in the treatment of non-small cell lung cancer.
    Wozniak AJ
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):62-6; discussion 71-2. PubMed ID: 10585010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients.
    Veronesi A; Crivellari D; Magri MD; Cartei G; Mansutti M; Foladore S; Monfardini S
    Eur J Cancer; 1996 Sep; 32A(10):1809-11. PubMed ID: 8983294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral vinorelbine and cisplatin with concomitant radiotherapy in stage III non-small cell lung cancer (NSCLC): a feasibility study.
    Beckmann G; Fietkau R; Huber RM; Kleine P; Schmidt M; Semrau S; Aubert D; Fittipaldo A; Flentje M
    Onkologie; 2006 Apr; 29(4):137-42. PubMed ID: 16601369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer.
    Evans WK; Le Chevalier T
    Eur J Cancer; 1996 Dec; 32A(13):2249-55. PubMed ID: 9038606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.